NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for disease-free survival


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


Refine Search
Display Mode: Context | Summary
African-Americans with colorectal cancer have poorer outcomes, lower survival rates
2009 NOV 29 ... for and can be effectively treated, yet African-Americans still have a profoundly lower survival rate than Caucasians," said Timothy L. Fitzgerald, MD, FACS, associate professor, ...
Subject: Weber Shandwick Worldwide
Price: $3.00
*
Erythropoiesis-stimulating agents associated with higher risk of venous thromboembolism
2009 NOV 29 ... analyzed the association between agent use and venous thromboembolism and overall survival in patients who were 65 years or older and diagnosed with colon, non-small cell lung, or ...
Subject: Journal of the National Cancer Institute
Price: $3.00
*
New bone research data have been reported by E. Chamoux and co-authors
2009 NOV 24 ... conferred a unique, intermediate osteoclast phenotype. In addition, we report that two survival-promoting kinases, protein kinase C zeta and phosphoinositide-dependent protein kinase ...
Subject: Bone Research
Price: $3.00
*
New explanation for nature's hardiest life form
2009 NOV 29 ... Got food poisoning? The cause might be bacterial spores, en extremely hardy survival form of bacteria, a nightmare for health care and the food industry and an enigma for ...
Subject: Swedish Research Council
Price: $3.00
*
New findings from Veterans Affairs Medical Center in the area of kidney failure cell biology described
2009 NOV 24 ... necrosis were at high risk for the development of stage 4 disease and had a reduced survival time when compared to control patients." Amdur and colleagues published ...
Subject: Kidney Failure Cell Biology
Price: $3.00
*
New findings in surgery described from University Hospital
2009 NOV 25 ... patency of the bypass and mortality was retrieved from patient records. A Kaplan-Meier survival analysis was performed to illustrate survival rates, limb salvage, and primary and ...
Subject: Surgery
Price: $3.00
*
New public health findings from University of Montreal described
2009 NOV 24 ... a small role. Feeling loved and listened to by one's children did not have an effect on survival. Maintaining an important role in the extended family was also significantly associated ...
Subject: Public Health
Price: $3.00
*
New surgery study findings have been reported by scientists at University of Michigan
2009 NOV 25 ... report, researchers in the United States conducted a study "To determine event free Survival (EFS) of children with Wilms tumor (WT) and metastatic liver disease at diagnosis ...
Subject: Surgery
Price: $3.00
In Cart
Researchers from Nagoya University describe findings in pediatrics
2009 NOV 28 ... and colleagues, Nagoya University.The researchers concluded: "Event-free survival did not significantly differ between patients with and without ES regardless of the ...
Subject: Pediatrics
Price: $3.00
*
Scientists at University of North Carolina publish research in surgery
2009 NOV 24 ... "The rate of successful salvage of these late neck metastases, defined in this study as disease-free survival for at least I year, has not been previously reported. Meta-analysis examining 33 ...
Subject: Surgery
Price: $3.00
*
Scientists at University of Queensland target pediatrics
2009 NOV 28 ... from Australia, "Pediatric liver transplantation has proven so successful that 10-yr survival post-transplantation is in excess of 70% and following transplantation, emphasis of ...
Subject: Pediatrics
Price: $3.00
*
Studies from University of Massachusetts yield new data on apoptosis
2009 NOV 24 ... that the tumor necrosis factor alpha (TNF alpha)-TNF receptor 2 (TNFR2)-NF kappa B cell survival pathway is active in postnatal day 2 (PND2) female AVPV and repressed in male ...
Subject: Apoptosis
Price: $3.00
*
Study findings on breast cancer are outlined in reports from University of Orebro
2009 NOV 23 ... its biological relevance in codon 72 heterozygous breast cancer patients (i.e., survival and age of disease onset). 199 postmenopausal cases were analyzed for LOH using ...
Subject: Breast Cancer
Price: $3.00
*
Study results from B. Mailey and colleagues in the area of biomedicine published
2009 NOV 23 ... Cox-regression analysis was used to assess the association of pathology with survival. Of 61,823 patients, 33 per cent (n = 20,305) of OLTs were secondary to hepatitis C ...
Subject: Biomedicine
Price: $3.00
*
Study results from Indiana University, Medical Department in the area of breast cancer published
2009 NOV 23 ... with a more aggressive disease, greater likelihood of recurrence, and decreased survival compared to women with HER2-negative breast cancer. Trastuzumab is a monoclonal antibody ...
Subject: Breast Cancer
Price: $3.00
*
Study results from M.R. Loebinger and colleagues update understanding of bronchiectasis
2009 NOV 24 ... (Mortality in bronchiectasis: a long-term study assessing the factors influencing survival. European Respiratory Journal, 2009;34(4):843-849). For more information, ...
Subject: Bronchiectasis
Price: $3.00
*
Tokai Pharmaceuticals Initiates ARMOR Clinical Development Program for TOK-001; First Ever Multi-Target Investigational Drug for Prostate Cancer
2009 NOV 23 ... cancer, chemotherapy is the only option at this point that has been shown to prolong survival. There is an urgent need for new treatments for patients with prostate cancer since ...
Subject: Tokai Pharmaceuticals
Price: $3.00
*
Total Nutraceutical Solutions Research Data Reveals Ability to Control Oxidative Stress
2009 NOV 23 ... and/or neutralize the oxidative stress effect and resulted in a 30% increase in survival. Vitamin D2 by itself had no effect on survival. TNS has acquired, from The ...
Subject: Total Nutraceutical Solutions, Inc.
Price: $3.00
*
Vitae Pharmaceuticals to Present at Windhover's Annual Therapeutic Area Partnerships Conference
2009 NOV 23 ... in blood pressure, as well as beneficial end organ protection effects and enhanced survival. In addition, preclinical studies showed VTP-27999 had picomolar inhibitory activity ...
Subject: Vitae Pharmaceuticals, Inc.
Price: $3.00
*
ZIOPHARM Presents Positive Palifosfamide Sarcoma Randomized Phase II Interim Data at Annual Meeting of the Connective Tissue Oncology Society
2009 NOV 23 ... and 61 eligible for analysis. The 61 patients were evaluated for progression-free survival (PFS) with 20 documented PFS events (doxorubicin alone = 14 events; palifosfamide + ...
Subject: ZIOPHARM Oncology, Inc.
Price: $3.00
*

Results 1 - 20      Next >




-----------------------
PR Login